The White House said the money would fund a range of biomedical initiatives including ones in precision medicine, cancer treatment and diagnosis, and brain research.
The company's Confidence assays are designed to detect if a woman has a high-risk HPV subtype and, if so, determine her risk of developing cervical pre-cancer or cancer.
NextGxDx estimates more than 60,000 genetic test products would come under FDA oversight, which, if accurate, industry players fear would overburden test developers.
The companies are planning to build a platform and database that can be used to improve and automate the interpretation of genomic data.
The analysis published by Charles Beagrie reports an approximately £20 million return on investment to the scientific community for every £1 million invested.
Researchers identified Neanderthal alleles associated with human conditions using genotypic and phenotypic information in health records for more than 28,000 individuals.
With data from the CanPREDDICT study, the partners will develop a test to predict the rate of disease progression in patients with chronic kidney disease.
Researchers relied on three typing methods to define two Yersinia pestis sub-populations that largely cluster by elevation in plague-prone regions of Uganda.
The new test distinguishes Zika from other viruses in mosquito vectors and launches during an ongoing outbreak that has prompted new CDC guidelines.